+Compare
AVNS
Stock ticker: NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
997.22M

AVNS Avanos Medical Forecast, Technical & Fundamental Analysis

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for AVNS with price predictions
07:00 PM EST Nov 29, 2023

AVNS in upward trend: 10-day moving average moved above 50-day moving average on November 08, 2023

The 10-day moving average for AVNS crossed bullishly above the 50-day moving average on November 08, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 30, 2023. You may want to consider a long position or call options on AVNS as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AVNS moved above its 50-day moving average on November 01, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNS advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 179 cases where AVNS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AVNS moved out of overbought territory on November 07, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where AVNS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVNS turned negative on November 28, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVNS broke above its upper Bollinger Band on November 01, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.810) is normal, around the industry mean (25.181). P/E Ratio (57.471) is within average values for comparable stocks, (79.543). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (1.218) is also within normal values, averaging (44.232).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was 12%, and the average quarterly price growth was 702%. VVOS experienced the highest price growth at 514%, while SHWGF experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was 10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

AVNS is expected to report earnings to rise 48.90% to 44 cents per share on February 27

Avanos Medical AVNS Stock Earnings Reports
Q4'23
Est.
$0.45
Q3'23
Beat
by $0.02
Q2'23
Missed
by $0.09
Q1'23
Missed
by $0.02
Q4'22
Beat
by $0.11
The last earnings report on November 01 showed earnings per share of 30 cents, beating the estimate of 28 cents. With 41.84K shares outstanding, the current market capitalization sits at 997.22M.
A.I. Advisor
published General Information

General Information

a provider of health and healthcare products, which prevents infection, eliminating pain and speeding recovery

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5405 Windward Parkway
Phone
+1 844 428-2667
Employees
4044
Web
https://www.avanos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NREAX12.31N/A
N/A
Neuberger Berman Real Estate A
IVKSX19.30N/A
N/A
VY® Invesco Comstock S
FSCRX24.82N/A
N/A
Fidelity® Small Cap Discovery
MRSKX21.41N/A
N/A
MFS Research International R6
SEQPX14.85N/A
N/A
Guggenheim World Equity Income P

AVNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
+1.89%
RVTY - AVNS
49%
Loosely correlated
-0.58%
VREX - AVNS
46%
Loosely correlated
-0.32%
CNMD - AVNS
44%
Loosely correlated
+1.03%
AORT - AVNS
40%
Loosely correlated
+0.62%
COO - AVNS
40%
Loosely correlated
+1.61%
More

Groups containing AVNS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
+1.89%
medical service
(undefined stocks)
48%
Loosely correlated
+0.19%
medical research
(undefined stocks)
47%
Loosely correlated
+0.14%
Medical Specialties
(undefined stocks)
46%
Loosely correlated
+0.28%
Medical Specialties
(undefined stocks)
46%
Loosely correlated
+0.28%
healthcare
(undefined stocks)
45%
Loosely correlated
+0.54%
More